应激性血糖升高比值联合糖化血红蛋白水平对老年急性缺血性脑卒中病人静脉溶栓后出血转化的预测价值

doi:10.3969/j.issn.1003-9198.2024.01.013

摘要/Abstract

摘要： 目的探讨应激性血糖升高比值(SHR)联合HbA1c对老年急性缺血性脑卒中(AIS)病人静脉溶栓后出血转化(HT)的预测价值。方法纳入2018年6月至2020年12月连云港市第一人民医院和江苏大学附属医院接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓AIS老年住院病人共234例,依据急性期内复查CT或MRI结果,将病人分为HT组(n=50)和非HT组(n=184)。收集并比较2组病人临床基线资料。采用多因素Logistic回归分析老年AIS病人rt-PA静脉溶栓后HT的危险因素,应用ROC曲线分析SHR、HbA1c及二者联合预测老年AIS病人rt-PA后HT的价值。结果 2组年龄、溶栓前NIHSS评分、FPG、HbA1c水平,房颤、TOAST分型和梗死大面积比例差异均有统计学意义(P<0.05或P<0.01)。多因素Logistic回归分析结果表明:高水平SHR(OR=39.443,95%CI:1.847～842.343)、HbA1c(OR=1.777,95%CI:1.091～2.859)以及大面积梗死(OR=3.093,95%CI:1.359～7.036)是老年AIS病人rt-PA静脉溶栓后HT的独立危险因素。HbA1c、SHR及二者联合预测老年AIS病人rt-PA静脉溶栓后HT风险的AUC分别为:0.631(95%CI:0.541～0.721)、0.656(95%CI:0.654～0.748)、0.741(95%CI:0.665～0.816)。HbA1c联合SHR预测的AUC显著大于两指标单独预测,差异有统计学意义(P均<0.05)。结论高水平SHR和HbA1c是老年AIS病人rt-PA静脉溶栓后HT的独立危险因素,两者联合可更好地预测老年AIS病人rt-PA静脉溶栓后HT风险。

关键词: 急性缺血性脑卒中, 出血转化, 应激性血糖升高比值, 糖化血红蛋白, 危险因素

Abstract: Objective To investigate the predictive value of stress hyperglycemia ratio (SHR) combined with glycosylated hemoglobin (HbA1c) on hemorrhagic transformation (HT) after intravenous thrombolysis in the elderly patients with acute ischemic stroke (AIS). Methods A total of 234 elderly AIS inpatients receiving intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) from the First People’s Hospital of Lianyungang and Affiliated Hospital of Jiangsu University from June 2018 to December 2020 were enrolled in this study. The patients were divided into HT group (n=50) and non-HT group (n=184)according to the results of computed tomography (CT) or magnetic resonance imaging (MRI) during the acute period. The clinical baseline data of the two groups were collected and compared. Multivariate Logistic regression analysis was used to analyze the risk factors for HT after rt-PA intravenous thrombolytic therapy in the elderly AIS patients. The receiver operating characteristic (ROC) curve was used to analyze the value of SHR, HbA1c and their combination in predicting HT after rt-PA intravenous thrombolytic therapy in the elderly AIS patients. Results There were statistically significant differences in age, pre-thrombolysis NIHSS score, the levels of fasting plasma glucose (FPG) and HbA1c, and the ratio of atrial fibrillation, TOAST classification and large infarct area between the two groups(P<0.05 or P<0.01). Multivariate Logistic regression analysis showed that high levels of SHR (OR=39.443, 95%CI:1.847-842.343) and HbA1c (OR=1.777, 95%CI:1.091-2.859), and large infarct area(OR=3.093, 95%CI:1.359-7.036) were the independent risk factors for HT after intravenous thrombolysis with rt-PA in the elderly AIS patients. The area under curve (AUC) of HbA1c, SHR and their combination to predict the risk of HT after intravenous thrombolysis with rt-PA in the elderly AIS patients was 0.631 (95%CI:0.541-0.721), 0.656 (95%CI:0.654-0.748) and 0.741 (95%CI:0.665-0.816), respectively. The AUC of HbA1c combined with SHR was significantly greater than that of the two indexes alone (P<0.05). Conclusions High levels of SHR and HbA1c are independent risk factors for HT after intravenous thrombolysis with rt-PA in the elderly AIS patients,and the combination of the two indexes shows significant value to predict the risk of HT after rt-PA intravenous thrombolytic therapy.

Key words: acute ischemic stroke, hemorrhagic transformation, stress hyperglycemia ratio, glycosylated hemoglobin, risk factor

中图分类号:

R 743.31

吴旭明, 柯先金, 孙波, 孙振杰. 应激性血糖升高比值联合糖化血红蛋白水平对老年急性缺血性脑卒中病人静脉溶栓后出血转化的预测价值[J]. 实用老年医学, 2024, 38(1): 54-58.

WU Xuming, KE Xianjin, SUN Bo, SUN Zhenjie. Predictive value of stress hyperglycemia ratio combined with glycosylated hemoglobin on hemorrhagic transformation after intravenous thrombolysis in elderly patients with acute ischemic stroke[J]. Practical Geriatrics, 2024, 38(1): 54-58.

参考文献

[1] WU S, WU B, LIU M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[2] VIRANI S S, ALONSO A, APARICIO H J, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association[J]. Circulation, 2021, 143(8):e254-e743.
[3] LU G, HE Q, SHEN Y, et al. Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke[J]. Int J Neurosci, 2018, 128(1):79-89.
[4] PACIARONI M, AGNELLI G, COREA F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study[J]. Stroke, 2008, 39(8):2249-2256.
[5] THOMAS S E, PLUMBER N, VENKATAPATHAPPA P, et al. A review of risk factors and predictors for hemorrhagic transformation in patients with acute ischemic stroke[J]. Int J Vasc Med, 2021, 2021:4244267.
[6] TZIOMALOS K, DIMITRIOU P, BOUZIANA S D, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome[J]. Metabolism, 2017, 67:99-105.
[7] HUANG Y W, YIN X S, LI Z P. Association of the stress hyperglycemia ratio and clinical outcomes in patients with stroke: a systematic review and meta-analysis[J]. Front Neurol, 2022, 13:999536.
[8] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中国全科医学, 2011, 14(35):4013-4017.
[9] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9):666-682.
[10] BROTT T, MARLER J R, OLINGER C P, et al. Measurements of acute cerebral infarction: lesion size by computed tomography[J]. Stroke, 1989, 20(7):871-875.
[11] ADAMS H P Jr, BENDIXEN B H, KAPPELLE L J, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1):35-41.
[12] QIU L, FU F, ZHANG W, et al. Prevalence, risk factors, and clinical outcomes of remote intracerebral hemorrhage after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis[J]. J Neurol, 2023, 270(2):651-661.
[13] 陈燕, 张秋, 尤年兴, 等. 急性缺血性脑卒中静脉溶栓后神经功能恢复及脑出血转化发生的影响因素分析[J]. 中华危重病急救医学, 2020, 32(11):1340-1345.
[14] 欧艳. NIHSS评分与SSS评分对脑梗死急诊溶栓后出血转化的预测价值[J]. 实用医学杂志, 2014, 30(19):3124-3126.
[15] MAZYA M, EGIDO J A, FORD G A, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (SITS) symptomatic intracerebral hemorrhage risk score[J]. Stroke, 2012, 43(6):1524-1531.
[16] 邹飞辉, 韩斌, 鲍健南, 等. 急性前循环大血管闭塞机械取栓术患者入院血糖对预后的影响[J]. 南京医科大学学报(自然科学版), 2022, 42(8):1176-1182.
[17] WANG X, TSUJI K, LEE S R, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke[J]. Stroke, 2004, 35(11 Suppl 1):2726-2730.
[18] KAUR J, ZHAO Z, KLEIN G M, et al. The neurotoxicity of tissue plasminogen activator?[J]. J Cereb Blood Flow Metab, 2004, 24(9):945-963.
[19] SHUKLA V, SHAKYA A K, PEREZ-PINZON M A, et al. Cerebral ischemic damage in diabetes: an inflammatory perspective[J]. J Neuroinflammation, 2017, 14(1):21.